Chronic Anticoagulation in Chronic Kidney Disease∗
Copyright policy )Chronic Anticoagulation in Chronic Kidney Disease∗
Bleeding in patients with chronic kidney disease (CKD) or “uremic bleeding” is a well-recognized complication. It has been described as far back as 1907 by Reisman [(1)][1], classically as a complication of Bright disease. The continued debate over the mechanism of this disease only highlights
- Baylor Jack and Jane Hamilton Heart and Vascular Hospital United States
- Baylor University Medical Center United States
- Baylor Scott & White Health United States
- Baylor University United States
Male, CHA2DS2-VASc score, Anticoagulants, arrhythmia, warfarin, Stroke, Atrial Fibrillation, Humans, atrial fibrillation, Female, thromboprophylaxis, Renal Insufficiency, Chronic, Cardiology and Cardiovascular Medicine, chronic kidney disease
Male, CHA2DS2-VASc score, Anticoagulants, arrhythmia, warfarin, Stroke, Atrial Fibrillation, Humans, atrial fibrillation, Female, thromboprophylaxis, Renal Insufficiency, Chronic, Cardiology and Cardiovascular Medicine, chronic kidney disease
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).7 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!